Literature DB >> 8062417

Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.

G Hasenfuss1, H Reinecke, R Studer, M Meyer, B Pieske, J Holtz, C Holubarsch, H Posival, H Just, H Drexler.   

Abstract

Expression of sarcoplasmic reticulum (SR) Ca(2+)-ATPase was shown to be reduced in failing human myocardium. The functional relevance of this finding, however, is not known. We investigated the relation between myocardial function and protein levels of SR Ca(2+)-ATPase in nonfailing human myocardium (8 muscle strips from 4 hearts) and in myocardium from end-stage failing hearts with dilated (10 muscle strips from 9 hearts) or ischemic (7 muscle strips from 5 hearts) cardiomyopathy. Myocardial function was evaluated by the force-frequency relation in isometrically contracting muscle strip preparations (37 degrees C, 30 to 180 min-1). In nonfailing myocardium, twitch tension rose with increasing rates of stimulation and was 76% higher at 120 min-1 compared with 30 min-1 (P < .02). In failing myocardium, there was no significant increase in average tension at stimulation rates above 30 min-1. At 120 min-1, twitch tension was decreased by 59% (P < .05) in dilated cardiomyopathy and 76% (P < .05) in ischemic cardiomyopathy compared with nonfailing myocardium. Protein levels of SR Ca(2+)-ATPase, normalized per total protein or per myosin, were reduced by 36% (P < .02) or 32% (P < .05), respectively, in failing compared with nonfailing myocardium. SR Ca(2+)-ATPase protein levels were closely related to SR Ca2+ uptake, measured in homogenates from the same hearts (r = .70, n = 16, and P < .005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062417     DOI: 10.1161/01.res.75.3.434

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  183 in total

1.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.

Authors:  M I Miyamoto; F del Monte; U Schmidt; T S DiSalvo; Z B Kang; T Matsui; J L Guerrero; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo.

Authors:  D Burkhoff; I Shemer; B Felzen; J Shimizu; Y Mika; M Dickstein; D Prutchi; N Darvish; S A Ben-Haim
Journal:  Heart Fail Rev       Date:  2001-01       Impact factor: 4.214

Review 3.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 4.  Electrophysiological modeling of cardiac ventricular function: from cell to organ.

Authors:  R L Winslow; D F Scollan; A Holmes; C K Yung; J Zhang; M S Jafri
Journal:  Annu Rev Biomed Eng       Date:  2000       Impact factor: 9.590

5.  Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution.

Authors:  Loren E Wold; Zhekang Ying; Kirk R Hutchinson; Markus Velten; Matthew W Gorr; Christina Velten; Dane J Youtz; Aixia Wang; Pamela A Lucchesi; Qinghua Sun; Sanjay Rajagopalan
Journal:  Circ Heart Fail       Date:  2012-06-01       Impact factor: 8.790

6.  Intracellular calcium and the relationship to contractility in an avian model of heart failure.

Authors:  C S Kim; A J Davidoff; T M Maki; A A Doye; J K Gwathmey
Journal:  J Comp Physiol B       Date:  2000-06       Impact factor: 2.200

Review 7.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 8.  The therapeutic potential of new insights into myocardial excitation-contraction coupling.

Authors:  M Scoote; P A Poole-Wilson; A J Williams
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

Review 9.  Perspectives of I(f) inhibition by ivabradine in cardiology.

Authors:  Michael Böhm; Jan-Christian Reil
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Protein Kinase A as a Promising Target for Heart Failure Drug Development.

Authors:  Nancy S Saad; Mohammad T Elnakish; Amany A E Ahmed; Paul M L Janssen
Journal:  Arch Med Res       Date:  2019-01-11       Impact factor: 2.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.